Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
7.30
-0.61 (-7.71%)
At close: Apr 28, 2026, 4:00 PM EDT
7.90
+0.60 (8.22%)
After-hours: Apr 28, 2026, 7:25 PM EDT
Alpha Tau Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Alpha Tau Medical stock have an average target of 8.67, with a low estimate of 5.00 and a high estimate of 12. The average target predicts an increase of 18.77% from the current stock price of 7.30.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 11, 2026.
Analyst Ratings
The average analyst rating for Alpha Tau Medical stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $7 → $9 | Strong Buy | Maintains | $7 → $9 | +23.29% | Mar 11, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +64.38% | Mar 10, 2026 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $5 | Buy → Hold | Downgrades | $5 | -31.51% | Mar 4, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +64.38% | Feb 24, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | -4.11% | Dec 10, 2025 |
Financial Forecast
Revenue This Year
963.90K
Revenue Next Year
7.71M
from 963.90K
Increased by 699.98%
EPS This Year
-0.53
from -0.53
EPS Next Year
-0.47
from -0.53
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.0M | 7.9M | |||
| Avg | 963,900 | 7.7M | |||
| Low | n/a | 7.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 723.5% | |||
| Avg | - | 700.0% | |||
| Low | - | 668.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.51 | -0.48 | |||
| Avg | -0.53 | -0.47 | |||
| Low | -0.53 | -0.45 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.